Research funder · Germany
European Foundation for the Study of Diabetes
Foundation
- Grants since 2016
- 353
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 1 093
- Funded works, all time
- 4 005
Grants
2018 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Bioengineering of insulin-secreting, immunoprotective 3D constructs using hydrogel scaffolds
Ekaterine Berishvili · University of Geneva
2018 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Regulation of insulin secretion by fusion pore dynamics
Sebastian Barg · Uppsala University
2018 · training · EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca
EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca — mentor: Stefano Del Prato, University of Pisa - Italy
Rumyana Boykova Dimova-Draganova · Medical University of Sofia
2018 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Metabolites and circulatory factors regulating skeletal muscle insulin sensitivity
Anna Krook · Karolinska Institutet
2018 · training · EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca
EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca — mentor: Fredrik Karpe, University of Oxford - UK
Jan Gojda · Charles University
2018 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Elucidating mechanisms of epigenetic changes in type 1 diabetes and treatment with DNA demethylating drugs
Nabil Djouder · National Cancer Research Center
2018 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
SIRP-alpha, a novel regulator of beta-cell viability
Noel G. Morgan · University of Exeter
2018 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Unravelling the mechanistic link between enterovirus infection and type 1 diabetes
Corrado Maria Cilio · Lund University
2017 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Investigation of the role of ER Ca2+ in the glucose regulation of glucagon secretion
Quan Zhang · University of Oxford
2017 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Inhibiting NAMPT to improve beta cell survival and function in type 1 diabetes
Paul Caton · King's College London
2017 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
New markers for pancreatic beta cell imaging in type 1 diabetes
Esteban Nicolas Gurzov · Université Libre de Bruxelles
2017 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Role of insulin-degrading enzyme (IDE) in hepatic insulin resistance
Irene Cózar-Castellano · Universidad de Valladolid
2017 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
A role for the intestine in type 1 diabetes autoimmunity
Valeria Sordi · San Raffaele Scientific Institute
2017 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Neuropeptide FF activates adipocyte browning and alleviates insulin resistance by TLR3 inhibition
Tamás Röszer · Universität Ulm
2017 · training · EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca
EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca — mentor: Rury Holman, University of Oxford - UK
Ernesto Maddaloni · Sapienza University of Rome
2017 · training · EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca
EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca — mentor: Chantal Mathieu, University of Leuven - Belgium
Shivani Misra · Imperial College London
2017 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Insulin resistance, brain inflammation and astrogliosis studied using PET-imaging in humans (ASTRO-PET)
Pirjo Nuutila · University of Turku
2017 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Direct reprogramming of human fibroblasts towards insulin-producing cells
Rosa Gasa · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2017 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
The true target of thiazolidinediones - a new approach for treatment of type 2 diabetes
Susanna Törnroth Horsefield · Lund University
2017 · training · EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca
EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca — mentor: Jens Juuls Holst, University of Copenhagen - Denmark
Teresa Mezza · Università Cattolica del Sacro Cuore
2017 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
A novel human peptide to treat type 2 diabetes
Shanta Persaud · King's College London
2017 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Molecular basis for aberrant immune response to microbial factors in type 1 diabetes
Jorma Toppari · University of Turku
2017 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Genetically engineered tolerogenic dendritic cells for antigen-specific immunotherapy for type 1 diabetes
Silvia Gregori · San Raffaele Scientific Institute
2017 · training · EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca
EFSD Future Leaders Mentorship Programme for Clinical Diabetologists supported by AstraZeneca — mentor: Hans-Ulrich Haering, University of Tuebingen - Germany
Giuseppe Daniele · University of Pisa
2016 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
CYP7B1 – an alternative regulator for the metabolic activity of thermogenic adipocytes
Joerg Heeren · University Medical Center Hamburg-Eppendorf
2016 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
CD3+CD56+ cells a novel human regulatory population: function and molecular mechanism in type 1 diabetes
Mario Galgani · “g Salvatore” National Research Council
2016 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Using single-cell transcriptomics to investigate the protective role of Dexi in islet destruction in type 1 diabetes
Christopher O’Callaghan · University of Oxford
2016 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Do exocrine – endocrine cell interactions induce inflammatory responses leading to type 1 diabetes?
Ben Giepmans · University Medical Center Groningen
2016 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Genetic causes of immune-dysregulation in early-onset type 1 diabetes
Carlos Penha-Concalves · Gulbenkian Science Institute
2016 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Role of exosome-mediated RNA transfer from immune cells to beta cells in type 1 diabetes development
Romano Regazzi · University of Lausanne
2016 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Challenging the DAGma of bioactive lipids in myocellular insulin resistance
Matthijs Hesselink · Maastricht University
2016 · research · EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Role of MAIT cells in type 1 diabetes, studies in patients and mouse models
Agnes Lehuen · Cochin Institute
2016 · research · EFSD European Research Programme on New Targets for Type 2 Diabetes supported by MSD
Osteokines new target opportunity for type 2 diabetes: effects of periostin and sclerostin on glucose metabolism
Nicolas Bonnet · University Geneva Hospital